We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Feb. 25, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Eli Lilly and Company (NYSE:LLY) and Alkermes, Inc. (NASDAQ:ALKS...
Health Education Answers recognized as an effective online tool by eHealthcare Leadership Awards and Web Marketing Association INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- Lilly USA recently...
CHICAGO, Jan. 22 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
Los Angeles Town Hall Speech Outlines Policies to Advance Medicine in New Decade LOS ANGELES, Jan. 14 /PRNewswire-FirstCall/ -- In the keynote address at a Town Hall Los Angeles luncheon event...
Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23...
Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23...
NEW YORK, Dec. 10 /PRNewswire-FirstCall/ -- -- Company remains focused on speeding innovation to patients and delivering greater value to customers. -- Five strategic business units...
INDIANAPOLIS, Dec. 4 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and...
INDIANAPOLIS, Nov. 30 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder...
Winners Can Receive Up to $15,000 Each to Donate to Nonprofit of Their Choice NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- The deadline to submit nominations for this year's Welcome Back Awards, a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.4 | -0.321070234114 | 747.5 | 770 | 743.5 | 3377 | 760.48169702 | DE |
4 | -11.4 | -1.50693985459 | 756.5 | 820 | 721 | 3866 | 757.27734396 | DE |
12 | -64.7 | -7.98962706841 | 809.8 | 859.4 | 672 | 4626 | 762.35858478 | DE |
26 | -100.8 | -11.9163021634 | 845.9 | 885 | 653 | 5108 | 787.83793774 | DE |
52 | 216.6 | 40.9839167455 | 528.5 | 885 | 527.5 | 5561 | 738.8355932 | DE |
156 | 498.6 | 202.271805274 | 246.5 | 885 | 202.3 | 2744 | 639.99706567 | DE |
260 | 626.82 | 529.945891106 | 118.28 | 885 | 108.56 | 2053 | 545.60995385 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions